Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2023-08-24 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Audit Report / Information Classification · 95% confidence The document is a special statement and independent opinion from the independent directors of the company regarding the use of company funds by controlling shareholders and related parties, as well as the company's external guarantees during the first half of 2023. It references regulatory guidelines and announcements from the China Securities Regulatory Commission (CSRC) related to listed companies' fund transactions and external guarantees. The document is a formal attestation and explanation rather than a full financial report or audit. It is short (576 characters) and focuses on compliance and independent director opinions rather than detailed financial data or results. Therefore, it fits best under Audit Report / Information (AR), which includes standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests, excluding full annual reports. The document is not an announcement of a report publication, nor is it a certification letter alone, but a special statement and independent opinion on specific regulatory matters. H1 2023
2023-08-24 Chinese
半年报监事会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company regarding the 18th meeting of the 8th Supervisory Board. It includes voting results on several agenda items, including approval of the 2023 semi-annual report and other internal matters. The document references other detailed reports and announcements disclosed on the same day but does not contain the full semi-annual report or detailed financial data itself. The document is short (833 characters) and serves as an official announcement of meeting resolutions and voting results. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-08-24 Chinese
半年报董事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 16th meeting of the 8th Board of Directors of the company. It includes details about the meeting date, attendance, and voting results on various agenda items such as approval of the 2023 semi-annual report, risk assessment report, related party transactions, and internal audit system revisions. The document does not contain the full semi-annual report or detailed financial data but refers to other disclosures for the full reports. It is a typical board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (899 characters), and it is not a full financial report or earnings release but a meeting decision announcement.
2023-08-24 Chinese
重药控股股份有限公司内部审计制度（2023年8月）
Audit Report / Information Classification · 95% confidence The document is titled '内部审计制度' which translates to 'Internal Audit System' or 'Internal Audit Policy'. It is a detailed internal audit policy document approved by the company's board of directors. The content includes the scope, organization, responsibilities, authority, management, supervision, and accountability related to internal audit functions within the company. It does not contain financial statements, financial results, or audit opinions typically found in audit reports or annual reports. It is not an announcement or a brief summary but a comprehensive internal governance document related to audit practices. This fits best under the category of Audit Report / Information (AR), which includes applied accounting principles and internal audit information, excluding full annual reports. The document is not a regulatory filing, report publication announcement, or any other category. Therefore, the classification is AR with high confidence. FY 2023
2023-08-24 Chinese
关于重药股份委托重庆科瑞制药（集团）有限公司药品商业生产暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related party transaction where the company (重药控股股份有限公司) discloses details about entrusting a subsidiary to produce pharmaceuticals. It includes transaction overview, parties involved, financial data, approval by the board, and independent director opinions. The document is a formal announcement of a corporate transaction involving related parties, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. It is not a regulatory certification or a report publication announcement. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about a related party transaction that does not fit other specific categories like M&A or Capital Update.
2023-08-24 Chinese
关于原持股5%以上股东减持计划实施完毕的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the completion of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the reduction in shareholding by Shenzhen Maoye (Group) Co., Ltd., including dates, quantities, and prices of shares sold. The document references compliance with securities laws and regulations and confirms that the reduction plan has been fully implemented. There is no financial report, earnings data, or management discussion present. The content fits the definition of a Major Shareholding Notification (MRQ), as it reports changes in significant share ownership levels crossing thresholds.
2023-08-21 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.